دورية أكاديمية

Gleason score and docetaxel response in advanced hormone-sensitive prostate cancer: The lower the better

التفاصيل البيبلوغرافية
العنوان: Gleason score and docetaxel response in advanced hormone-sensitive prostate cancer: The lower the better
المؤلفون: Omer Dizdar, Deniz Can Guven, Gurkan Guner, Mustafa Erman, Mutlu Hayran
المصدر: Journal of Oncological Sciences, Vol 5, Iss 2, Pp 45-48 (2019)
بيانات النشر: Turkiye Klinikleri, 2019.
سنة النشر: 2019
المجموعة: LCC:Neoplasms. Tumors. Oncology. Including cancer and carcinogens
مصطلحات موضوعية: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
الوصف: Aim: Recently, three randomized controlled trials evaluated the addition of docetaxel to ADT in advanced hormone-sensitive prostate cancer (aHSPC). Interestingly, all trials showed a trend towards improved OS in the subgroup of patients with Gleason
نوع الوثيقة: article
وصف الملف: electronic resource
اللغة: English
تدمد: 2452-3364
العلاقة: http://www.sciencedirect.com/science/article/pii/S2452336418300967Test; https://doaj.org/toc/2452-3364Test
DOI: 10.1016/j.jons.2019.06.001
الوصول الحر: https://doaj.org/article/38b91bdbfa5842a3918ad42b195e3c97Test
رقم الانضمام: edsdoj.38b91bdbfa5842a3918ad42b195e3c97
قاعدة البيانات: Directory of Open Access Journals
الوصف
تدمد:24523364
DOI:10.1016/j.jons.2019.06.001